Table 3 Morphologic Distribution and Frequency of most common cancers in East Azerbaijan Province in 2015-2016

Neoplasm, Malignant

Male

4

7.0

Neoplasm, Malignant

Male

14

8.1

Neoplasm, Malignant

Male

1

0.14

Female

2

8.0

Female

9

5.7

Female

43

6.09

Epithelial Tumor, Malignant

Male

1

1.8

Epithelial Tumor, Malignant

Male

4

2.3

Carcinoma

Male

-

-

Female

-

-

Female

2

1.3

Female

28

3.96

Squamous Cell Carcinoma

Male

1

1.8

Squamous Cell carcinoma

Male

131

75.7

Papillary Carcinoma

Male

1

0.14

Female

8

32.0

Female

141

88.7

Female

-

-

Adenocarcinoma/NOS

Male

24

42.1

Adenocarcinoma/NOS

Male

9

5.2

Squamous Cell Carcinoma

Male

-

-

Female

8

32.0

Female

5

3.1

Female

1

0.14

Adenocarcinoma, Intestinal Type

Male

19

33.3

Adenocarcinoma, Intestinal Type

Male

12

6.9

Adenocarcinoma

Male

-

-

Female

4

16.0

Female

1

.6

Female

1

0.14

Adenocarcinoma, Diffuse Type

Male

4

7.0

Adenocarcinoma, Diffuse Type

Male

-

-

Tubular Adenocarcinoma

Male

-

-

Female

1

4.0

Female

-

-

Female

1

0.14

Mucinous Adenocarcinoma

Male

1

1.8

Mucinous Adenocarcinoma

Male

1

.6

Mucinous Adenocarcinoma

Male

-

-

Female

-

-

Female

-

-

Female

1

0.14

Sebaceous Adenocarcinoma

Male

-

-

Sebaceous Adenocarcinoma

Male

-

-

Signet Ring Cell Carcinoma

Male

-

-

Female

1

4.0

Female

-

-

Female

1

0.14

Signet Ring Cell Carcinoma

Male

3

5.3

Signet Ring Cell Carcinoma

Male

1

.6

Ductal Carcinoma

Male

12

1.6

Female

1

4.0

Female

-

-

Female

587

83.14

Others

Male

-

-

Others

Male

1

.6

Medullary Carcinoma

Male

-

-

Female

-

-

Female

1

.6

Female

8

1.13

Total

Male

57

100.0

Total

Male

173

100.0

Lobular Carcinoma

Male

-

-

Female

25

100.0

Female

159

100.0

Female

17

2.40

Non-Cardiac Gastric Cancer

Colorectal Cancer

Infiltrating Ductal and Lobular Carcinoma

Male

-

-

Neoplasm, Malignant

Male

55

9.9

Neoplasm, Malignant

Male

20

5.4

Female

1

0.14

Female

31

11.1

Female

33

10.7

Phylloides Tumor Malignant

Male

-

-

Epithelial Tumor, Malignant

Male

7

1.3

Epithelial Tumor, Malignant

Male

1

.3

Female

2

0.28

Female

6

2.1

Female

-

-

Myeloid Sarcoma

Male

-

-

Squamous Cell Carcinoma

Male

3

.5

Squamous Cell Carcinoma

Male

2

.5

Female

1

0.14

Female

1

.4

Female

2

.7

Unknown

Male

-

-

Adenocarcinoma/NOS

Male

281

50.4

Adenocarcinoma/NOS

Male

330

89.9

Female

-

-

Female

147

52.5

Female

254

82.7

Total

Male

14

100.0

Adenocarcinoma, Intestinal Type

Male

155

27.8

Adenocarcinoma, Intestinal Type

Male

-

-

Female

692

100.0

Female

71

25.4

Female

1

.3

Lung Cancer

Adenocarcinoma, Diffuse Type

Male

18

3.2

Adenocarcinoma, Diffuse Type

Male

-

-

Neoplasm, Malignant

Male

88

19.86

Female

6

2.1

Female

1

.3

Female

40

9.02

Mucinous Adenocarcinoma

Male

4

.7

Mucinous Adenocarcinoma

Male

6

1.6

Malignant Tumor, Small Cell Type

Male

2

0.45

Female

1

.4

Female

3

1.0

Female

-

-

Sebaceous Adenocarcinoma

Male

-

-

Sebaceous Adenocarcinoma

Male

-

-

Malignant Tumor, Spindle Cell Type

Male

-

-

Female

-

-

Female

-

-

Female

1

0.22

Signet Ring Cell Carcinoma

Male

26

4.7

Signet Ring Cell Carcinoma

Male

4

1.1

Carcinoma

Male

11

2.48

Female

13

4.6

Female

4

1.3

Female

5

1.12

Others

Male

2

.4

Others

Male

4

1.2

Small Cell Carcinoma, NOS

Male

12

2.70

Female

3

1.1

Female

6

1.8

Female

3

0.67

Unknown

Male

6

1.1

Unknown

Male

-

-

Non-small Cell Carcinoma

Male

5

1.12

Female

1

.4

Female

-

-

Female

1

0.22

Total

Male

551

100.0

Total

Male

367

100.0

Squamous Cell Carcinoma

Male

172

38.81

Female

279

100.0

Female

307

100.0

Female

54

12.18

Thyroid Cancer

Prostate

Adenocarcinoma

Male

27

6.09

Neoplasm, Malignant

Male

4

1.70

Neoplasm, Malignant

Male

19

5.09

Female

9

2.03

Female

8

3.40

Female

-

-

Carcinoid Tumor, NOS

Male

-

-

Papillary Carcinoma

Male

9

3.82

Carcinoma

Male

78

20.91

Female

4

0.90

Female

28

11.91

Female

-

-

Bronchiolo-Alveolar Adenocarcinoma, NOS

Male

3

0.67

Squamous Cell Carcinoma

Male

-

-

Carcinoma, Undifferentiated ,NOS

Male

1

0.26

Female

-

-

Female

1

0.42

Female

-

-

Signet Ring Cell Carcinoma,

Male

1

0.22

Papillary Adenocarcinoma

Male

41

17.44

Squamous Cell Carcinoma

Male

1

0.26

Female

-

-

Female

101

42.97

Female

-

-

Sarcoma, NOS

Male

-

-

Oxyphilic Adenocarcinoma

Male

1

0.42

Transitional Cell Carcinoma, NOS

Male

3

0.80

Female

1

0.22

Female

6

2.55

Female

-

-

Spindle cell Sarcoma

Male

1

0.22

Follicular Adenocarcinoma

Male

2

0.85

Papillary Transitional Cell Carcinoma

Male

3

0.80

Female

-

-

Female

13

5.52

Female

-

-

Total

Male

322

100.0

Insular Carcinoma

Male

-

-

Adenocarcinoma

Male

266

71.31

Female

118

100.0

Female

1

0.42

Female

-

-

Bladder Cancer

Gender

Papillary Carcinoma, Follicular Variant

Male

3

1.27

Adenocarcinoma, Intestinal Type

Male

2

0.53

Neoplasm, Malignant

Male

17

3.82

Female

13

5.53

Female

-

-

Female

2

0.44

Medullary Carcinoma with Amyloid Stroma

Male

1

0.42

Unknown

Male

-

-

Transitional Cell Carcinoma, NOS

Male

217

48.76

Female

-

Female

-

-

Female

49

11.01

Mixed Medullary Carcinoma

Male

2

.84

Total

Male

373

100.0

Papillary Carcinoma

Male

1

0.22

Female

-

Female

-

-

Female

1

0.22

Medullary Carcinoma, NOS

Male

-

Squamous Cell Carcinoma

Male

1

0.22

Female

3

1.27

Female

-

-

Total

Male

62

100.0

Papillary Transitional Cell Carcinoma

Male

117

26.29

Female

173

100.0

Female

34

7.64

Adenocarcinoma

Male

2

0.44

Female

1

0.22

Carcinoid tumor, NOS

Male

3

0.66

Female

-

-

Total

Male

358

100.0

Female

87

100.0